@article{oai:tsukuba.repo.nii.ac.jp:00047725, author = {Masuda, N. and Toi, M. and Yamamoto, N. and Iwata, H. and Kuroi, K. and 坂東, 裕子 and BANDO, Hiroko and Ohtani, S. and Takano, T. and Inoue, K. and Yanagita, Y. and Kasai, H. and Morita, S. and Sakurai, T. and Ohno, S.}, issue = {4}, journal = {Breast Cancer}, month = {Jul}, pages = {407--415}, title = {Efficacy and safety of trastuzumab, lapatinib, and paclitaxel neoadjuvant treatment with or without prolonged exposure to anti-HER2 therapy, and with or without hormone therapy for HER2-positive primary breast cancer: a randomised, five-arm, multicentre, open-label phase II trial}, volume = {25}, year = {2018}, yomi = {バンドウ, ヒロコ} }